Like Sun Pharma, Strides Arcolab: Deepak Shenoy

Deepak Shenoy, Founder of Capitalmind.in told CNBC-TV18, "We like Sun Pharma and Strides Arcolab, as a disclosure we have recommended and are long in these stocks. Both of them are really about the fact that Sun Pharma is already merged with Ranbaxy, Shasun Pharmaceuticals and Strides Arcolab are going to merge, it is stuck up in some kind of approval right now but these will continue to perform and with the dollar at Rs 66, this is a space that will definitely benefit.""Whether it is midcap pharmaceuticals or large cap pharmaceuticals, the sector as a whole is worth looking at because although results were kind of lacklustre compared to what we expected, going forward the rupee should be a tremendous help to it," he said.